CareCloud, Inc.

CCLD Healthcare Health Information Services

CareCloud, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.5 million, up 8.72% from fiscal 2024. In the quarter to June 2026, revenue grew 16.5%, EPS fell 100.0%, free cash flow grew 6.15% and total debt rose 44,345.3%, each against the same quarter a year earlier.

1.85 0.08 −4.15%
Market cap
$82.0M
P/E
26.4×
Fwd P/E
12.5×
Dividend yield
—
F-score
6/9
Altman Z
3.29
Beneish M
−3.25
Dividend safety
n/a

Insider Decisions trades per month

Total sells 0.05
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell 1 — — — — — — — — — — —
Insider Ownership 15.73%

Capital & Financial Ratios $m

Market Cap 82.01
Revenue 128.64
Net Income 7.99
Free Cash Flow 19.60
Net Debt 24.83
Current Ratio 1.02
Debt/Equity 2.20 (above 2: weak)
P/E ratio 26.43
Fwd P/E 12.50
P/S ratio 0.61
P/B ratio 4.52
Past 5Y EPS Growth —
This Y EPS Growth 175.00% (at or above 15%: strong)
Next Y EPS Growth 10.91%
Next Y revenue growth 8.13%
Next 5Y EPS Growth 62.03% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/S against its own 10 years 46.89%
10-year low 10-year high
P/B against its own 10 years 96.42%
10-year low 10-year high
EV/Sales against its own 10 years 60.08%
10-year low 10-year high
EV/FCF against its own 10 years 28.25%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 3 5 4 13
Receivables 12 13 15 14
Inventory 0 1 1 0
Other 5 4 4 3
23 25 26 34
2023 2024 2025 Q'26
Payables 6 5 7 6
ST’ Debt — — — —
Other — — 1 0
23 20 24 33

Compound Annual Growth %

10y 5y 3y
Sales 17.97% 2.77% (4.61%)
Cash Flow 0.00% 0.00% 10.53%
Earnings 0.00% 0.00% 0.00%
Book Value 14.86% (10.08%) (16.36%)

Revenue $m

Mar Jun Sep Dec Year
’26 31 32 — — —
’25 28 27 31 34 120
’24 26 28 29 28 111
’23 30 29 29 28 117
’22 35 37 34 33 139
’21 30 34 38 37 140
’20 22 20 32 32 105
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 4 7 — — —
’25 5 7 7 9 29
’24 4 4 7 5 21
’23 1 6 4 4 15
’22 3 5 7 6 21
’21 1 1 5 6 13
’20 (4) 1 (1) 3 (1)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2 6 — — —
’25 4 5 6 6 21
’24 2 3 5 3 13
’23 (2) 3 1 1 4
’22 0 2 3 3 9
’21 (1) (1) 3 3 3
’20 (6) 0 (3) 1 (9)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.01) 0.00 — — —
’25 (0.04) 0.04 0.04 0.04 0.10
’24 (0.02) (0.14) (0.04) 0.00 (0.28)
’23 (0.28) (0.37) (0.42) (3.00) (4.11)
’22 (0.19) (0.07) (0.18) (0.22) (0.67)
’21 (0.36) (0.27) (0.15) (0.01) (0.77)
’20 (0.42) (0.65) (0.46) 0.01 (1.79)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 0.68 0.29 2.55 3.25 3.76 4.86 2.72 0.68 1.01 1.14

Analyst estimates 2026–2028

Powerpack
High 1.33 5.44 5.65 5.50 13.40 12.84 6.98 4.51 4.84 4.75
People
People Employees 2,050 1,700 2,400 2,700 3,700 4,100 4,150 3,600 3,650 3,650
Revenue/emp, $m 0.01 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03
Income, $m
Income, $m Revenue 24 32 51 64 105 140 139 117 111 120
Gross margin, % 45.22 44.42 38.17 36.09 38.34 37.74 39.18 39.50 45.11 46.51
EBT (9) (5) (2) (1) (9) 3 6 (49) 8 11
EBT margin, % (35.11) (17.28) (4.54) (1.05) (8.29) 2.14 4.04 (41.89) 7.23 9.13
Net income (9) (6) (2) (1) (9) 3 5 (49) 8 11
Depreciation 5 4 3 5 13 16 16 59 14 15
Per share, $
Per share, $ Revenue 2.44 2.89 4.31 5.33 8.29 9.60 9.19 7.47 6.86 3.19
Earnings (0.95) (0.69) (0.59) (0.60) (1.79) (0.77) (0.67) (4.11) (0.28) 0.10
Cash flow (0.09) 0.03 0.58 0.63 (0.07) 0.92 1.40 0.99 1.28 0.76
Capex (0.05) (0.06) (0.09) (0.21) (0.61) (0.73) (0.78) (0.74) (0.46) (0.21)
Free cash flow (0.13) (0.04) 0.49 0.42 (0.68) 0.19 0.62 0.25 0.82 0.54
Book value 0.70 1.84 3.32 3.54 7.99 6.73 6.73 2.66 3.08 1.57
Shares, m 10 11 12 12 13 15 15 16 16 38
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 36.50
P/S 0.27 0.92 0.88 0.76 1.09 0.66 0.30 0.24 0.53 0.92
P/B 0.94 1.44 1.15 1.15 1.14 0.94 0.41 0.67 1.19 1.85
EV/Sales 0.49 0.85 0.64 0.48 0.91 0.66 0.28 0.31 0.51 0.91
EV/FCF (8.88) (64.81) 5.58 6.16 (11.12) 33.06 4.20 9.51 4.23 5.32
Cash, $m
Cash, $m Operating cash flow (1) 0 7 8 (1) 13 21 15 21 29
Capex 0 (1) (1) (3) (8) (11) (12) (12) (7) (8)
Free cash flow (1) 0 6 5 (9) 3 9 4 13 21
Balance, $m
Balance, $m Working capital (7) 5 18 20 16 6 12 0 5 1
Total debt 9 0 0 0 0 8 8 10 0 0
Net debt 5 (4) (14) (20) (21) (2) (4) 7 (5) (3)
Shareholders’ equity 7 20 39 43 101 98 102 42 50 60
Returns, %
Returns, % ROA (34.72) (28.21) (19.04) (13.95) (23.34) (8.04) (7.28) (60.14) (5.97) 4.89
ROIC (39.64) (17.65) (6.45) 0.18 (6.43) 2.31 4.24 (60.81) 12.77 12.59
ROE (86.98) (55.61) (23.55) (17.77) (31.50) (11.26) (10.10) (89.75) (9.75) 7.12
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

CareCloud, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
SPOK Spok Holdings, Inc. $224.5M 17.7× 16.2× −1.89% (below 0%: shrinking) −9.09% (below 0%: shrinking) −2.00% (below 0%: shrinking) 80.47% 15.50% Compare
AMWL American Well Corporation $210.6M — (loss-making) — (loss-making) −26.59% (below 0%: shrinking) n/m +266.38% (above 0%: growing) 52.95% (18.36%) Compare
SY So-Young International Inc. Sponsored ADR $198.9M — (loss-making) 12.8× +40.84% (above 0%: growing) n/m −798.37% (below 0%: shrinking) 44.11% (8.64%) Compare
OPRX OptimizeRx Corp. $166.7M 35.4× 23.0× −29.77% (below 0%: shrinking) n/m +89.86% (above 0%: growing) 76.51% (0.43%) Compare
DH Definitive Healthcare Corp. $144.3M — (loss-making) — (loss-making) −9.14% (below 0%: shrinking) n/m +21.44% (above 0%: growing) 73.45% (12.23%) Compare
HCAT Health Catalyst, Inc. $135.5M — (loss-making) — (loss-making) −12.68% (below 0%: shrinking) n/m +64.26% (above 0%: growing) 49.46% (51.75%) Compare
LFMD LifeMD, Inc. $118.6M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
CCLD CareCloud, Inc. $82.0M 26.4× 12.5× +16.45% (above 0%: growing) n/m +6.15% (above 0%: growing) 45.24% 5.84%
DRIO DarioHealth Corp. $50.3M — (loss-making) — (loss-making) −3.58% (below 0%: shrinking) n/m −0.74% (below 0%: shrinking) 61.66% (125.15%) Compare
Median of peers $155.5M — 16.2× −6.36% — +10.35% 67.56% (13.65%)

All 51 Health Information Services stocks →

CareCloud, Inc. (CCLD) key facts

  • Strength: CareCloud, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.5 million, up 8.72% from fiscal 2024.
  • CareCloud, Inc. (CCLD) is a Health Information Services company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, CCLD traded at $1.85, a market capitalization of $82.0 million.
  • Return on equity was 7.12% and debt-to-equity 2.20.
  • Its Piotroski F-score is 6 out of 9 and its Altman Z-score is 3.29 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

CareCloud, Inc. (CCLD) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/CCLD · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com